As a very active patient supporter in an effort to help some of my doctor's seriously ill patients, I am also invited to attend any of the many 3-day seminars he teaches worldwide. I always try to attend at least the local ones, though I have taken part in many in Europe also. I must say I have learned a few things and am very active sharing info with many of you who contact me behind the scenes. Thank God, I do not have to take the "garbage" that some of the people responding to my posts are throwing at me here. But then I put these people into the "extremely toxic" drawer. I have been able to help some; even someone's cancer is now gone, and this makes up for the trash and insults that some people seem to need to throw at me.
Please know that I am a messenger only. That I have experienced what I talk about down to the darkest levels myself and I am in constant touch with many other severely ill patients who are still going through it and trying to hold on to the positives when the going gets harder at times.
A seminar I attended last year on "The Latest Findings and Research in the Field of Chemical and Metal detoxification" included several superb guest speakers. Bob Jones, Research Scientist, the inventor of the Cavitat instrument to measure bone density of the jaw bone, was one of them. He works very closely with Prof. Boyd Haley, Kentucky University, developer of the TOPAS test. Prof. Haley testifies before Congress re root canals. You can find his writings all over the net.
This was a talk about toxins stronger than mercury or any man-made chemical; the scientific link between jaw bone infections and neurodegenerative diseases.
The seminar was attended by many MD's and DDS's and other practitioners, all of them in an effort to help their patients to get well, all of them dealing with Lyme.
Here is a part of Bob Jones' lecture:
ONCOGENE PROTEIN INHIBITION BY ORAL TOXINS
Inhibition by endodontic toxins both in infected root canalled teeth and endodontic bone lesions by thio -either compounds observed in Affinity Labeling of the Four [4] oncogene proteins. This invitro research upholds the scientific invivo research by Dr. Weston Price and Dr Edward G. Rosennow. With the advent of Proteomics scientific data that was not available during the time of these two researchers opens the case on Focal Infection once again. Focal infection "theory" was maligned by the American Dental Assoc. because of lack scientific data and a flaw in the published research published as a bacterial infection which was not always present. and a manipulation of the numbers by Dr's Holman and Grossman. What this research shows is the disease connection was indeed focal but one of toxic origin.
Damage to the four proteins inside of the mitochondria was substantional in the form of inhibiting these proteins from functioning. The inhibition ofP53, P21, P27, and CDK2 was substantial at minute amounts of these toxins extracted from Root canalled teeth and separately from over 400 bone fragments removed for biopsy from endodontic lesions. At a dilute 5 micro liters of toxicity the average human protein was inhibited by as much as 54%. At 40 micro liters dilute toxin this inhibition soared to over 80% in all four proteins.
The avg. toxin leaked into the blood stream and neuro systems from these sources was established by washing 3 times in 150 ml of sterile water and then washing in 150 ML of sterile water 10 straight days on a 24 hour basis. The level of exposure remained at 45 ML of exposure each 24 hours. The chronic exposures to these minute amounts of endotoxins which have been proven carcinogenic inhibit the binding ability to our DNA therefore rendering the cell to a none functional status until the carcinogenic dose is reached and the cell then turns malignant.
The loss of function also inhibits glycolization of GTP and GDP which leaves a gamma phosphatase residue triggering an antibody response identified as Human Lupus. This researcher believes that this research is relevant to the start of most if not all cancers define the pathway all cancers take in the cellular structure.
Bob Jones, CEO CAVITAT Medical Technologies, Inc.